Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling

Rosiglitazone (RGZ), a thiazolidinedione ligand of the peroxisome proliferator-activated receptor (PPAR)-γ, has been recently described as possessing antitumoral properties. We investigated RGZ effect on cell proliferation in two cell line models (SW13 and H295R) of human adrenocortical carcinoma (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantini, Giulia, Lombardi, Adriana, Piscitelli, Elisabetta, Poli, Giada, Ceni, Elisabetta, Marchiani, Sara, Ercolino, Tonino, Galli, Andrea, Serio, Mario, Mannelli, Massimo, Luconi, Michaela
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491299/
https://www.ncbi.nlm.nih.gov/pubmed/18670617
http://dx.doi.org/10.1155/2008/904041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491299/
https://www.ncbi.nlm.nih.gov/pubmed/18670617
http://dx.doi.org/10.1155/2008/904041

Ejemplares similares